Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cronos Group Inc. - Common Share (NQ: CRON )

1.970 -0.030 (-1.50%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cronos Group Inc. - Common Share

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
37 38 Next >
The Canadian Cannabis Report- Monday, Feb. 21
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
Lost Money in Cronos Group, Inc.?
From Gibbs Law Group
Via Business Wire
Global Cannabis Extract Market To Surpass $38B By 2030, Key Players Include Tilray, Canopy Growth, Aurora
According to Coherent Market Insights, the global cannabis extract market is estimated to be valu... 
Via Benzinga
NASDAQ:CRON Shareholder Notice: Investigation over Potential Wrongdoing at Cronos Group Inc.
San Diego, CA -- (SBWIRE) -- 02/16/2022 -- Certain directors of Cronos Group Inc. are under investigation over potential breaches of fiduciary duties by certain officers and directors at Cronos Group... 
Via SBWire
Cronos Group Provides Bi-Weekly MCTO Status Update
Cronos Group Inc. (NASDAQ:CRON) (TSX: 
Via Benzinga
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
Thinking About Buying Stock In Pieris Pharmaceuticals, Baidu Or Cronos Group?
Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings b... 
Via Benzinga
Cronos Group Earnings Preview
Cronos Group (NASDAQ:CRON) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
7 Best Stocks to Buy for a Recession
These low-beta recession stocks to buy have robust cash flows to sustain their businesses while paying regular dividends. 
Via InvestorPlace
10 Biggest Price Target Changes For Tuesday
Wells Fargo lowered DraftKings Inc. (NASDAQ: DKNG) price target from $41 to $19. DraftKings shares dropped 5.8% to $16.28 in pre-market trading. 
Via Benzinga
"Seed-To-Sale" Pot Stocks Index Faltered This Past Week After Two-Week Resurgence
Unfortunately, the turnaround in cannabis stocks did not hold, with the index dropping -5.5% this past week. 
Via Talk Markets
Cronos Group Q3 Financial Results Show Major Improvement
Cronos Group, a constituent in our Pure-Play Pot Stock Index, yesterday reported markedly improved Q3 financials for the period ending September 30, 
Via Talk Markets
Cronos Q3 Revenue Grows 79% YoY To $20.4M, Audit Committee Completes Evaluation
Cronos Group Inc. (NASDAQ:CRON) (TSX: 
Via Benzinga
Lost Money in Cronos Group, Inc.?
From Gibbs Law Group
Via Business Wire
Cannabis Stocks Are Up For The Second Week In A Row
Almost all the largest cap 
Via Talk Markets
7 Tempting Sin Stocks to Profit From the Pandemic’s Most Popular Vices
After the recent market decline, investors are discovering that vices may not a bad thing to invest in. Here are 7 top sin stocks to buy now. 
Via InvestorPlace
Cannabis Stocks Have Bounced Back From Last Week's 52-Week Lows
All the largest cap 
Via Talk Markets
Cannabis Stock Gainers And Losers From February 1, 2022
GAINERS: MedMen Enterprises (OTC:MMNFF) shares closed up 58.51% at $0.16 
Via Benzinga
New Kids On The Block: Is A Second Wave Of Canadian Cannabis Here?
Cannara’s Valleyfield Facility This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Cannabis Stock Gainers And Losers From January 31, 2022
GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76 
Via Benzinga
Most Cannabis Stocks Have Descended Below Their Previous 52-Week Lows
Is now the time to buy one or two of the deeply discounted cannabis stocks? The majority of them are now trading at new lows. 
Via Talk Markets
Cannabis Stock Gainers And Losers From January 28, 2022
GAINERS: BioHarvest Sciences (OTC:CNVCF) shares closed up 19.61% at $0.33 
Via Benzinga
Cannabis Stock Gainers And Losers From January 27, 2022
GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 8.27% at $0.03 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022
Upgrades 
Via Benzinga
The Canadian Cannabis Report- Monday, Jan. 24
The past, present and future of the Canadian cannabis sector based on the MCCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
Cannabis Stock Gainers And Losers From January 21, 2022
GAINERS: Item 9 Labs (OTC: 
Via Benzinga
Cannabis Movers & Shakers: Akerna, iAnthus, Cronos Group, WSU's Cannabis Research Center
Akerna Taps Current COO Ray Thompson As President & COO Akerna Corp (NASDAQ: 
Via Benzinga
7 Dividend Stocks Trading at Attractive Valuations
These dividend stocks also trade at attractive valuations. With these names, investors can benefit from dividend gains as well as capital gains. 
Via InvestorPlace
Cronos Promotes John Griese, Former Exec At Nestlé, PepsiCo And Supreme Cannabis
Canadian cannabis company Cronos Group (NASDAQ:CRON) promot... 
Via Benzinga
Cannabis Stock Gainers And Losers From January 18, 2022
GAINERS: Item 9 Labs (OTC: 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.